Xsome

Xsome Biotech Inc. is dedicated to developing exosome therapies for a variety of diseases and novel drug delivery vehicles. Currently, XO101, a therapy based on pulmonary spheroid cell-derived exosomes for the treatment of Acute Respiratory Distress Syndrome (ARDS), has received clinical trial approval.